Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
about
Targeting RTK Signaling Pathways in CancerThe gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferationA polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathwaySingle nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudyFGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis.eQTL Mapping Using RNA-seq DataASEQ: fast allele-specific studies from next-generation sequencing data.Recommendations for Accurate Resolution of Gene and Isoform Allele-Specific Expression in RNA-Seq Data.An unsupervised learning approach to find ovarian cancer genes through integration of biological dataHereditary breast cancer: ever more pieces to the polygenic puzzle.Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.Low-risk susceptibility alleles in 40 human breast cancer cell linesAn Integrative Genomics Approach for Associating Genome-Wide Association Studies Information With Localized and Metastatic Prostate Cancer PhenotypesData analysis issues for allele-specific expression using Illumina's GoldenGate assayVariation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer.Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breastAllele-specific CDH1 downregulation and hereditary diffuse gastric cancer.rs2981582 is associated with FGFR2 expression in normal breastMPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements.Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesisAssociation between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancerGenetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer.FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype.Cutis verticis gyrata and alopecia areata: a synchronous coincidence?NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.Acute ethanol alters multiple histone modifications at model gene promoters in the cerebral cortex.Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.Mammary gland growth factors: roles in normal development and in cancer.Evidence of expression variation and allelic imbalance in Crohn's disease susceptibility genes NOD2 and ATG16L1 in human dendritic cellsA structure-guided approach to creating covalent FGFR inhibitorsIdentification of Novel Susceptibility Genes for Breast Cancer - Genome-Wide Association Studies or Evaluation of Candidate Genes?Breast cancer susceptibility: current knowledge and implications for genetic counsellingUsing LASSO regression to detect predictive aggregate effects in genetic studies.FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancerIntegrative eQTL-based analyses reveal the biology of breast cancer risk lociAssociation of FGFR2 gene polymorphisms with the risk of breast cancer in population of West SiberiaLoss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancerA study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India
P2860
Q26781278-955CA5EC-13E5-4CB6-831F-51F4DF7CFD56Q27322396-09E83EF6-49C8-4D39-B220-288C62C2043BQ28302540-D43D6D26-2E5C-452A-BB91-F1B34377EB67Q30427359-3C8E9422-EC6F-4C7A-BA95-E6BF07C6F050Q30592934-EC077CE0-9E41-4BD7-9D65-62ABE6C53026Q30625155-246F868E-3A08-40AE-B6E2-68E5640AF482Q30936481-C56E9157-B8B5-4C7B-9AB9-5C7668E04850Q30950123-D44695DE-1D80-4131-8C21-32FE7F86287AQ30990983-FBA18D2C-92DD-4DA4-AEF1-5BAE53CC5EAFQ33356511-3A65532E-C488-46F0-B845-57B2D7EF2548Q33461922-4555470E-33B1-4524-940E-B57ED418309AQ33483075-44964911-49AE-48DF-9FEF-2418826773D1Q33565740-25DA02C5-5011-456E-B374-322662CDE79DQ33588055-09ACEEF1-8220-489A-B7FC-F7F71CC56524Q33590989-393DC4B8-887D-46DB-930F-6214AA737F07Q33627202-2F833789-E2BC-472E-8B1B-DF2475189359Q33630653-64C16AD2-08F8-4368-ABED-D7C603BC6B8DQ33702141-A10A6E0B-4D9D-4AED-A7E8-410A21DD86CAQ33708991-9C8D7633-DD28-4D97-B632-78C248ACDB77Q33750087-B21E2625-A1C3-496C-B502-77BD2230B655Q33770092-257DCDE7-63AC-4A9D-86BD-25A1D7330215Q33816374-7A35174B-4ED4-4CE2-A6B8-0C1DA66C3132Q33850399-F2E0657E-94AB-4365-A261-09E4D4FD0432Q33892319-0824CE88-9B88-4509-AF8C-E6BBE9F3F6A8Q33921638-92A9378E-737C-4ED5-8C55-B26728820350Q33934319-97285111-0F61-473D-A94C-DE795F0ED410Q33958257-65F76212-7673-416C-BA11-D75550ED2B5EQ33981307-D7688090-49AB-4A13-B247-485C1C26FB8CQ34014659-D11C604F-7745-41DB-A389-DCDAA694422CQ34056080-E75BB46D-27F8-41A9-AE8F-163F831B7E08Q34061522-050A3B7A-2B74-4A5C-9580-20717D605F0EQ34096129-C1292B72-059F-4247-88A2-DDB98F399A7DQ34161642-D5870720-05E2-47CD-AA37-7CCA3642CAF2Q34177648-A5FB83BB-238B-45D4-8F43-B6C593700B5AQ34179460-72C4F4BF-D46F-47D3-9DD9-6EFC0EFFDB5EQ34194044-DF93F1B9-CF93-4DD8-A467-7D0303A2FA61Q34194768-8F409B03-B70F-49AE-A297-544254B8F4E8Q34328151-C123D229-3832-4359-B051-861FD2CBE40FQ34358404-17BA2F1F-B529-4C95-B0D7-D1A7EF3F7652Q34379582-6E7CC45D-C75D-46AA-ADD3-BFF0CC327A61
P2860
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
@ast
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
@en
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
@nl
type
label
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
@ast
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
@en
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
@nl
prefLabel
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
@ast
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
@en
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
@nl
P2093
P2860
P50
P1433
P1476
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
@en
P2093
Andrew E Teschendorff
Bruce A J Ponder
Kerstin B Meyer
Martin O'Reilly
P2860
P356
10.1371/JOURNAL.PBIO.0060108
P407
P577
2008-05-01T00:00:00Z